Effectors of cellular senescence states
细胞衰老状态的效应器
基本信息
- 批准号:8278573
- 负责人:
- 金额:$ 31.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-04-01 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAgeAgingAreaBeliefBiologicalBiological AssayBiological MarkersBiological ModelsCaloric RestrictionCell AgingCell Culture TechniquesCell divisionCellsChromatinChromatin StructureCollaborationsCollectionCyclin-Dependent Kinase Inhibitor 2ADNADNA DamageDataDetectionDrug or chemical Tissue DistributionElderlyEpigenetic ProcessEvaluationEventEvolutionFunctional disorderGenerationsGoalsGrowthHealthHeterochromatinHumanIndividualKnowledgeLeadLifeLinkLongevityMacaca mulattaMalignant NeoplasmsMeasuresMemoryMethodsMicroscopicModelingMonitorMusNormal CellNormal tissue morphologyNutrientOncogenesOrganismOxidative StressPapioPathologyPathway interactionsPolycombPrimatesProcessReactive Oxygen SpeciesRelaxationRodentRoleSignal PathwaySirtuinsSiteStem cellsStimulusStressTelomere ShorteningTissuesTumor SuppressionTumor Suppressor ProteinsUp-RegulationWorkage relatedbasecell agecell typechromatin modificationcohortexhaustionfootgenome-widein vivoin vivo Modelinsulin signalingmouse modelpleiotropismreproductiveresearch studyresponseretinoblastoma tumor suppressorsenescencetelomeretraittumorultraviolet irradiation
项目摘要
DESCRIPTION (provided by applicant): Replicative cellular senescence is a phenomenon of irreversible growth arrest triggered by the accumulation of a discrete number of cell divisions. The great majority of normal cell types from all vertebrate species examined display this response. It is becoming increasingly evident that what has classically been described as cellular senescence is a collection of interrelated states that can be triggered by distinct intrinsic and extrinsic stimuli. The underlying cause of senescence due to replicative exhaustion is telomere shortening. In addition, it is now apparent that many types of stress, reactive oxygen species, pharmacological agents, and even nutrient imbalances can trigger a senescence response. Activation of some oncogenes also induces senescence in normal cells, and recent data have implicated cellular senescence as an important in vivo tumor suppression mechanism. In contrast, the connections between cellular senescence and the aging of organisms are significantly more tenuous. The necessary first step is to distinguish senescent cells from the majority of healthy but quiescent cells found in normal tissues. We, and others, have recently developed a method based on the microscopic detection of DNA damage markers localized to telomeres, designated the `TIF' assay (for `telomere dysfunction-induced foci'). TIFs are a robust biomarker of telomere-initiated senescence, which we used to demonstrate a marked age-associated accumulation of senescent cells in normal primate tissues. This proposal is aimed to give us a better understanding of multiple cellular senescence processes, focusing on their roles in organismal aging. Aim 1 will examine the in vivo occurrence of telomere-induced senescence in mouse, primate and human models, and probe the links between cellular senescence and pathways that functionally influence aging. Aim 2 will extend recent studies linking genome-wide changes in chromatin structure with cellular senescence by developing new assays to assess in vivo states of heterochromatin in cells and tissues. These new biomarkers of cellular senescence will then be applied to the models developed in Aim 1. Aim 3 will seek to discover what causes the age-dependent upregulation of the cyclin-dependent kinase inhibitor p16, an important effector implicated in regulating multiple senescent states. PUBLIC HEALTH RELEVANCE: Replicative cellular senescence was discovered and first described as an irreversible growth arrest triggered by the accumulation of a discrete number of cell divisions. These findings generated two hypotheses regarding the significance of cellular senescence: that it contributes to aging, and that it suppresses cancer. Recent data have implicated cellular senescence as an important in vivo tumor suppression mechanism in a variety of human and mouse tissues. In contrast to tumor suppression, the connections between cellular senescence and the aging of organisms are significantly more tenuous. The necessary first step is to distinguish senescent cells from the majority of healthy but quiescent cells found in normal tissues. This proposal will develop new biomarkers of cellular senescence that will be applied in vivo investigate the occurrence of senescent cells in rodents, primates and humans. Mechanisms that lead to the generation of senescent cells will also be investigated, as well as the persistence of senescent cells.
描述(由申请人提供):复制性细胞衰老是由离散数量的细胞分裂累积引发的不可逆生长停滞的现象。所有检查的脊椎动物物种的普通细胞类型绝大多数都显示出此反应。越来越明显的是,经典被描述为细胞衰老是相互关联的状态的集合,可以由独特的内在刺激和外在刺激触发。复制疲劳引起的衰老的根本原因是端粒缩短。此外,现在很明显,许多类型的压力,活性氧,药理学剂甚至营养失衡都会触发衰老反应。某些癌基因的激活还会诱导正常细胞的衰老,并且最近的数据将细胞衰老视为体内肿瘤抑制机制的重要性。相比之下,细胞衰老与生物体衰老之间的联系明显更脆弱。必要的第一步是将衰变细胞与正常组织中发现的大多数健康但静止的细胞区分开。我们和其他人最近开发了一种基于定位于端粒的DNA损伤标记的显微镜检测的方法,该标志物指定了“ TIF”测定法(用于“端粒功能障碍诱导的灶”)。 TIF是端粒引起的衰老的强大生物标志物,我们用来证明在正常灵长类动物组织中衰老细胞显着相关的衰老积累。该建议的目的是使我们更好地了解多个细胞衰老过程,重点是它们在有机体衰老中的作用。 AIM 1将检查小鼠,灵长类动物和人类模型中端粒诱导的衰老的体内发生,并探测细胞衰老与功能影响衰老的途径之间的联系。 AIM 2将扩展最新的研究,将染色质结构的全基因组变化与细胞衰老联系起来,通过开发新测定,以评估细胞和组织中异染色质的体内状态。然后,这些新的细胞衰老生物标志物将应用于AIM 1中开发的模型。AIM3将寻求发现导致细胞周期蛋白依赖性激酶抑制剂p16的年龄依赖性上调的是什么,这是一种与调节多个衰老状态有关的重要效应。公共卫生相关性:发现了复制性细胞衰老,并首先被描述为不可逆的生长停滞,这是由于分散数量的细胞分裂的积累而引起的。这些发现对细胞衰老的重要性产生了两个假设:它有助于衰老,并抑制癌症。最近的数据表明,细胞衰老是多种人和小鼠组织中体内抑制机制的重要重要性。与肿瘤抑制相反,细胞衰老与生物体衰老之间的连接明显更脆弱。必要的第一步是将衰变细胞与正常组织中发现的大多数健康但静止的细胞区分开。该建议将开发出新的细胞衰老生物标志物,并将在体内应用,研究啮齿动物,灵长类动物和人类中衰老细胞的发生。还将研究导致衰老细胞产生的机制,以及衰老细胞的持续性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John M Sedivy其他文献
John M Sedivy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John M Sedivy', 18)}}的其他基金
Project 1: Activation of Alternative L1 Lifecycles in the CNS with age and Alzheimer's Disease
项目 1:中枢神经系统中 L1 生命周期的激活随着年龄和阿尔茨海默病的增加
- 批准号:
10581521 - 财政年份:2016
- 资助金额:
$ 31.6万 - 项目类别:
Role of Retrotransposon Activity in Neurodegeneration and Alzheimer's Disease
逆转录转座子活性在神经退行性变和阿尔茨海默氏病中的作用
- 批准号:
10333657 - 财政年份:2016
- 资助金额:
$ 31.6万 - 项目类别:
Somatic Activation of Retrotransposition: A New Molecular Mechanism of Aging?
逆转录转座的体细胞激活:衰老的新分子机制?
- 批准号:
9334684 - 财政年份:2016
- 资助金额:
$ 31.6万 - 项目类别:
Somatic Activation of Retrotransposition: A new Molecular Mechanism of Aging?
逆转录转座的体细胞激活:一种新的衰老分子机制?
- 批准号:
9522255 - 财政年份:2016
- 资助金额:
$ 31.6万 - 项目类别:
Project 1: Activation of Alternative L1 Lifecycles in the CNS with age and Alzheimer's Disease
项目 1:中枢神经系统中 L1 生命周期的激活随着年龄和阿尔茨海默病的增加
- 批准号:
10333661 - 财政年份:2016
- 资助金额:
$ 31.6万 - 项目类别:
Somatic Activation of Retrotransposition: A New Molecular Mechanism of Aging?
逆转录转座的体细胞激活:衰老的新分子机制?
- 批准号:
9755302 - 财政年份:2016
- 资助金额:
$ 31.6万 - 项目类别:
Role of Retrotransposon Activity in Neurodegeneration and Alzheimer's Disease
逆转录转座子活性在神经退行性变和阿尔茨海默氏病中的作用
- 批准号:
10581509 - 财政年份:2016
- 资助金额:
$ 31.6万 - 项目类别:
2015 Aging, Biology of Gordon Research Conference and Gordon Research Seminar
2015年衰老、生物学戈登研究会议暨戈登研究研讨会
- 批准号:
8975254 - 财政年份:2015
- 资助金额:
$ 31.6万 - 项目类别:
相似国自然基金
TBX20在致盲性老化相关疾病年龄相关性黄斑变性中的作用和机制研究
- 批准号:82220108016
- 批准年份:2022
- 资助金额:252 万元
- 项目类别:国际(地区)合作与交流项目
LncRNA ALB调控LC3B活化及自噬在体外再生晶状体老化及年龄相关性白内障发病中的作用及机制研究
- 批准号:81800806
- 批准年份:2018
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
APE1调控晶状体上皮细胞老化在年龄相关性白内障发病中的作用及机制研究
- 批准号:81700824
- 批准年份:2017
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
KDM4A调控平滑肌细胞自噬在年龄相关性血管老化中的作用及机制
- 批准号:81670269
- 批准年份:2016
- 资助金额:55.0 万元
- 项目类别:面上项目
老年人一体化编码的认知神经机制探索与干预研究:一种减少与老化相关的联结记忆缺陷的新途径
- 批准号:31470998
- 批准年份:2014
- 资助金额:87.0 万元
- 项目类别:面上项目
相似海外基金
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 31.6万 - 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 31.6万 - 项目类别:
The contribution of air pollution to racial and ethnic disparities in Alzheimer’s disease and related dementias: An application of causal inference methods
空气污染对阿尔茨海默病和相关痴呆症的种族和民族差异的影响:因果推理方法的应用
- 批准号:
10642607 - 财政年份:2023
- 资助金额:
$ 31.6万 - 项目类别:
Effects of Aging on Neuronal Lysosomal Damage Responses Driven by CMT2B-linked Rab7
衰老对 CMT2B 相关 Rab7 驱动的神经元溶酶体损伤反应的影响
- 批准号:
10678789 - 财政年份:2023
- 资助金额:
$ 31.6万 - 项目类别: